Case Studies

Explore how QInscribe transforms complex regulatory writing challenges into successful submission-ready outcomes for pharmaceutical and biotechnology sponsors.

Submit an RFI

Speak to an Expert

Close-up of a laboratory pipette dispensing liquid into glass test tubes beside a microscope, with a blue and orange background.

Delivering a Complex Phase 1 Paediatric Asthma CSR Within Accelerated Timelines: A Quality-Driven Approach

A top 20 global pharma sponsor required a Phase 1 paediatric asthma CSR within an aggressive six-month timeline. Discover how QInscribe delivered a submission-ready report with minimal revisions and sponsor recognition. Read more.

Clinician in white coat completing a medical form on a clipboard, with patient hands, keyboard, pill bottles and blister packs on the desk.

Delivering a Complex Phase 1 Paediatric Asthma CSR Within Accelerated Timelines: A Quality-Driven Approach

A top 20 global pharma sponsor required a Phase 1 paediatric asthma CSR within an aggressive six-month timeline. Discover how QInscribe delivered a submission-ready report with minimal revisions and sponsor recognition. Read more.

Delivering a Complex Phase 1 Paediatric Asthma CSR Within Accelerated Timelines: A Quality-Driven Approach

A top 20 global pharma sponsor required a Phase 1 paediatric asthma CSR within an aggressive six-month timeline. Discover how QInscribe delivered a submission-ready report with minimal revisions and sponsor recognition. Read more.

Delivering a Complex Phase 1 Paediatric Asthma CSR Within Accelerated Timelines: A Quality-Driven Approach

A top 20 global pharma sponsor required a Phase 1 paediatric asthma CSR within an aggressive six-month timeline. Discover how QInscribe delivered a submission-ready report with minimal revisions and sponsor recognition. Read more.

Delivering a Complex Phase 1 Paediatric Asthma CSR Within Accelerated Timelines: A Quality-Driven Approach

A top 20 global pharma sponsor required a Phase 1 paediatric asthma CSR within an aggressive six-month timeline. Discover how QInscribe delivered a submission-ready report with minimal revisions and sponsor recognition. Read more.

Delivering a Complex Phase 1 Paediatric Asthma CSR Within Accelerated Timelines: A Quality-Driven Approach

A top 20 global pharma sponsor required a Phase 1 paediatric asthma CSR within an aggressive six-month timeline. Discover how QInscribe delivered a submission-ready report with minimal revisions and sponsor recognition. Read more.

Let's Create Your Next Success Story

Whether it’s a first-in-class submission or a complex resubmission, our team has the expertise to move it forward.

Speak to an Expert